Literature DB >> 7460189

Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards.

D Godenèche, J C Madelmont, M F Moreau, R Plagne, G Meyniel.   

Abstract

Chlorambucil, phenyl acetic mustard, melphalan and mitoclomine are aromatic nitrogen mustard derivatives. These drugs show a fairly wide range of chemical reactivity and lipophilicity. In the series presently investigated, the more hydrophilic compounds (melphalan and phenyl acetic mustard) are the more toxic to mice and also the more active against Moloney sarcoma implanted IP in mice. No clear relation could be shown between the alkylating activity and the biological efficiency. All the compounds induce changes in DNA synthesis with differences between the timing of alterations and recovery. Nevertheless, return to pretreatment levels of thymidine incorporation is more rapid in the bone marrow and intestinal mucosa following administration of the drugs, than in tumor cells. The 14C-ethyl labeled compounds was used to investigate the part of the carrying structure in their disposition in mice.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7460189     DOI: 10.1007/bf00578555

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  27 in total

1.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

2.  A method for the determination of desoxyribonucleic acid, ribonucleic acid, and phosphoproteins in animal tissues.

Authors:  G SCHMIDT; S J THANNHAUSER
Journal:  J Biol Chem       Date:  1945       Impact factor: 5.157

3.  The metabolism of chlorambucil.

Authors:  A McLean; D Newell; G Baker
Journal:  Biochem Pharmacol       Date:  1976-10-15       Impact factor: 5.858

4.  Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.

Authors:  G P Wheeler; B J Bowdon; J A Grimsley; H H Lloyd
Journal:  Cancer Res       Date:  1974-01       Impact factor: 12.701

5.  Investigations into the lymphopaenic and immunosuppressive properties of the antitumour agent, mitoclomine.

Authors:  M Fox; R W Rees; D H Bennett; L Henry
Journal:  Lymphology       Date:  1971-06       Impact factor: 1.286

6.  Estimation of chlorambucil, phenyl acetic mustard and prednimustine in human plasma by high-performance liquid chromatography.

Authors:  D R Newell; L I Hart; K R Harrap
Journal:  J Chromatogr       Date:  1979-09-11

7.  Alkylating properties of phosphoramide mustard.

Authors:  M Colvin; R B Brundrett; M N Kan; I Jardine; C Fenselau
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

8.  Use of a single tissue extract to determine cellular protein and nucleic acid concentrations and rate of amino acid incorporation.

Authors:  R W Wannemacher; W L Banks; W H Wunner
Journal:  Anal Biochem       Date:  1965-05       Impact factor: 3.365

9.  Pharmacokinetics of the absorption, distribution, and elimination of melphalan in the dog.

Authors:  R L Furner; R K Brown; G Duncan
Journal:  Cancer Treat Rep       Date:  1977-12

10.  The distribution of radioactivity in tissues of the rat following the administration of a nitrogen mustard derivative; p-di-(2-chloroethyl) amino-DL-phenyl[beta-14C] alanine.

Authors:  P COHN
Journal:  Br J Cancer       Date:  1957-06       Impact factor: 7.640

View more
  9 in total

1.  Inter- and intraindividual differences in oral chlorambucil pharmacokinetics.

Authors:  P Hartvig; B Simonsson; G Oberg; I Wallin; H Ehrsson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.

Authors:  N H Greig; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard.

Authors:  H Ehrsson; I Wallin; B Simonsson; P Hartvig; G Oberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  The action of azimexone on the cells of the hemopoietic system in mice, especially after damage with X-rays.

Authors:  K D Friedberg; K Mengel; E Schlick
Journal:  Radiat Environ Biophys       Date:  1983       Impact factor: 1.925

5.  Studies on the pharmacokinetics of chlorambucil and prednimustine in man.

Authors:  D R Newell; A H Calvert; K R Harrap; T J McElwain
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

6.  Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil.

Authors:  S Genka; J Deutsch; U H Shetty; P L Stahle; V John; I M Lieberburg; F Ali-Osman; S I Rapoport; N H Greig
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

7.  Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain.

Authors:  N H Greig; E M Daly; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration.

Authors:  N H Greig; S Genka; E M Daly; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

9.  Pharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and beta, beta-difluorochlorambucil (CB 7103) in mice.

Authors:  F Y Lee; P Coe; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.